Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jeff Connell

Biographic Data

ID7975271
NAMEJeff Connell
GIVEN NAMESJeff
FAMILY NAMEConnell
SIGNATURECONNELL J
AFFILIATIONSSt. Columcille's Hospital
ORCID0000-0001-7241-8025
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2010
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’

    Open Access•Ita Fitzgerald, Laura J Sahm et al.•ARTICLE•Frontiers in Psychiatry•2024

    Antipsychotic-induced weight gain (AIWG) contributes significantly to the 2-3-fold higher rates of obesity seen amongst those living with a severe mental illness (SMI). 1 Clinically significant weight gain (≥7% increase in weight) has been linked to almost all antipsychotics. 2 Adjunctive metformin treatment has been demonstrated to effectively reduce AIWG. 3 However, metformin's position within current AIWG management algorithms is typically lim…

  • Mapping of serological testing and Sars-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020

    Open Access•Laura Bubba, Peter Simmonds et al.•ARTICLE•Journal of Global Health•2021

    BACKGROUND: The SARS-CoV-2 pandemic spread across Europe from February 2020. While robust SARS-CoV-2 serological assays were quickly developed, only limited information on applied serological testing is available. We describe the extent and nature of SARS-CoV-2 serological testing used in Europe and assess the links between epidemiology, mitigation strategies applied and seroprevalence. METHODS: An online questionnaire on SARS-CoV-2 serology was …

  • BMI ≥ 50 kg/m 2 is associated with a younger age of onset of overweight and a high prevalence of adverse metabolic profiles

    Open Access•Jean O’Connell, Jeff Connell et al.•ARTICLE•Public Health Nutrition•2010

    Objective To study the demographic and clinical parameters of three different categories of obesity, with particular focus on a cohort of individuals with BMI ≥ 50 kg/m 2 , the fastest growing category of obesity. Design Over 700 obese individuals were studied (186 with BMI = 30–39 kg/m 2 , 316 with BMI = 40–49 kg/m 2 and 290 with BMI ≥ 50 kg/m 2 ). Results Median BMI was 51 kg/m 2 for patients who reported onset of overweight before 15 years of …

No prominent works on this page.

  • BMI ≥ 50 kg/m 2 is associated with a younger age of onset of overweight and a high prevalence of adverse metabolic profiles

    Open Access•Jean O’Connell, Jeff Connell et al.•ARTICLE•Public Health Nutrition•2010

    Objective To study the demographic and clinical parameters of three different categories of obesity, with particular focus on a cohort of individuals with BMI ≥ 50 kg/m 2 , the fastest growing category of obesity. Design Over 700 obese individuals were studied (186 with BMI = 30–39 kg/m 2 , 316 with BMI = 40–49 kg/m 2 and 290 with BMI ≥ 50 kg/m 2 ). Results Median BMI was 51 kg/m 2 for patients who reported onset of overweight before 15 years of …

  • Mapping of serological testing and Sars-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020

    Open Access•Laura Bubba, Peter Simmonds et al.•ARTICLE•Journal of Global Health•2021

    BACKGROUND: The SARS-CoV-2 pandemic spread across Europe from February 2020. While robust SARS-CoV-2 serological assays were quickly developed, only limited information on applied serological testing is available. We describe the extent and nature of SARS-CoV-2 serological testing used in Europe and assess the links between epidemiology, mitigation strategies applied and seroprevalence. METHODS: An online questionnaire on SARS-CoV-2 serology was …

  • Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’

    Open Access•Ita Fitzgerald, Laura J Sahm et al.•ARTICLE•Frontiers in Psychiatry•2024

    Antipsychotic-induced weight gain (AIWG) contributes significantly to the 2-3-fold higher rates of obesity seen amongst those living with a severe mental illness (SMI). 1 Clinically significant weight gain (≥7% increase in weight) has been linked to almost all antipsychotics. 2 Adjunctive metformin treatment has been demonstrated to effectively reduce AIWG. 3 However, metformin's position within current AIWG management algorithms is typically lim…

Medicine (3 works) · Diet and metabolism studies (2 works) · Internal Medicine (2 works) · Obesity (2 works) · 2019-20 coronavirus outbreak (1 work) · Antibody (1 work) · Antipsychotic (1 work) · Birth, Development, and Health (1 work) · Body mass index (1 work) · Body weight (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae